CSN (NYSE: SID) revenue
CSN reported revenue of BRL 44,798m for fiscal 2025, 2.5% more than in fiscal 2024 (BRL 43,687m). Since fiscal 2016 its revenue has grown by 161.2%, an average growth of 11.3% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | BRL 44,798m | +2.5% | BRL 4,817m | 10.8% |
| 2024 | BRL 43,687m | −3.9% | BRL 4,270m | 9.8% |
| 2023 | BRL 45,438m | +2.4% | BRL 5,187m | 11.4% |
| 2022 | BRL 44,362m | −7.4% | BRL 7,641m | 17.2% |
| 2021 | BRL 47,912m | +59.4% | BRL 20,540m | 42.9% |
| 2020 | BRL 30,064m | +18.2% | BRL 5,714m | 19.0% |
| 2019 | BRL 25,436m | +10.7% | BRL 3,542m | 13.9% |
| 2018 | BRL 22,969m | +24.0% | BRL 6,947m | 30.2% |
| 2017 | BRL 18,525m | +8.0% | BRL 2,984m | 16.1% |
| 2016 | BRL 17,149m | — | BRL 1,945m | 11.3% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of Brazilian reais, except per-share amounts.
Questions about the revenue of CSN
- How much revenue did CSN make in fiscal 2025?
- CSN reported revenue of BRL 44,798m for fiscal 2025, compared with BRL 43,687m in fiscal 2024.
- How much has the revenue of CSN grown?
- Between fiscal 2016 and fiscal 2025 it went from BRL 17,149m to BRL 44,798m: 161.2% more, an average growth of 11.3% a year.
- What was the best year for revenue at CSN?
- Of its last 10 fiscal years, fiscal 2021, with BRL 47,912m.
- Where do the figures for CSN come from?
- From the annual report (Form 20-F) that CSN files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 20-F) that CSN files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on CSN: the CSN page · annual accounts · net income · dividends paid.
More companies from Brazil and the rest of the region: Latin American stocks.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.